Skip to content

Mary L. Forsling

4 papers in the library · 168 citations · publishing 2001-2011

Papers

Sort Most recent Most cited

Pharmacogenetic studies of change in cortisol on ecstasy (MDMA) consumption

Journal of Psychopharmacology October 3, 2011 Kim Wolff, Eva-Maria Tsapakis, Carmine Maria Pariante et al. 37 citations

In this study we investigate the association of cytochrome P450 enzyme CYP2D6, catechol-O-methyl transferase (COMT, Val158Met) and serotonin transporter promoter (5-HTTLPR) genotypes on change in cortisol concentration following 3, 4-methylenedioxy-methamphetamine (MDMA, 'ecstasy') consumption. Forty-eight subjects (30 males, mean age 23 years), self-nominating regular clubbers provided 'in the...

Action of MDMA (Ecstasy) and Its Metabolites on Arginine Vasopressin Release

Annals of the New York Academy of Sciences June 1, 2002 John K. Fallon, Dhwanil Shah, Andrew T. Kicman et al. 54 citations

A bstract : 3,4‐Methylenedioxymethamphetamine (MDMA) has been reported to cause hyponatraemia, which appears to result from inappropriate secretion of the antidiuretic hormone arginine vasopressin (AVP). After administration of a low dose of ( R,S )‐MDMA (40 mg) to eight healthy drug‐free male volunteers, concentrations of AVP in plasma increased significantly at 1, 2, and 4 hours. Although no...

The effect of 3,4‐methylenedioxymethamphetamine (MDMA, ?ecstasy?) and its metabolites on neurohypophysial hormone release from the isolated rat hypothalamus

British Journal of Pharmacology February 1, 2002 Mary L. Forsling, John K. Fallon, Darshna Shah et al. 77 citations

Methylenedioxymethamphetamine (MDMA, “ecstasy”), widely used as a recreational drug, can produce hyponatraemia. The possibility that this could result from stimulation of vasopressin by MDMA or one of its metabolites has been investigated in vitro . Release of both oxytocin and vasopressin from isolated hypothalami obtained from male Wistar rats was determined under basal conditions and...

Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine ("ecstasy"): is metabolism a contributory factor?

Journal of Pharmacy and Pharmacology October 2001 Mary L. Forsling, John K. Fallon, A T Kicman et al.

The aim of this investigation was to examine the effect of 3,4-methylenedioxymethamphetamine (MDMA) administration on arginine vasopressin (AVP) release. (R,S)-MDMA (40 mg) was administered to eight normally hydrated healthy male volunteers (22-32 years) and blood samples were collected up to 24 h. Plasma was assayed for AVP and cortisol by radioimmunoassays, and for MDMA and the N-demethylated...